The role of gut hormones in glucose homeostasis

被引:473
作者
Drucker, Daniel J.
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada
关键词
D O I
10.1172/JCI30076
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The gastrointestinal tract has a crucial role in the control of energy homeostasis through its role in the digestion, absorption, and assimilation of ingested nutrients. Furthermore, signals from the gastrointestinal tract are important regulators of gut motility and satiety, both of which have implications for the long-term control of body weight. Among the specialized cell types in the gastrointestinal mucosa, enteroendocrine cells have important roles in regulating energy intake and glucose homeostasis through their actions on peripheral target organs, including the endocrine pancreas. This article reviews the biological actions of gut hormones regulating glucose homeostasis, with an emphasis on mechanisms of action and the emerging therapeutic roles of gut hormones for the treatment of type 2 diabetes mellitus.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 125 条
[1]   Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice [J].
Ahrén, B ;
Holst, JJ ;
Mårtensson, H ;
Balkan, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 404 (1-2) :239-245
[2]   Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes [J].
Ahrén, B ;
Holst, JJ ;
Efendic, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1043-1048
[3]   Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes [J].
Ahrén, B ;
Landin-Olsson, M ;
Jansson, PA ;
Svensson, M ;
Holmes, D ;
Schweizer, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2078-2084
[4]   Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes [J].
Ahrén, B ;
Simonsson, E ;
Larsson, H ;
Landin-Olsson, M ;
Torgeirsson, H ;
Jansson, PA ;
Sandqvist, M ;
Båvenholm, P ;
Efendic, S ;
Eriksson, JW ;
Dickinson, S ;
Holmes, D .
DIABETES CARE, 2002, 25 (05) :869-875
[5]   Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice [J].
Baggio, L ;
Kieffer, TJ ;
Drucker, DJ .
ENDOCRINOLOGY, 2000, 141 (10) :3703-3709
[6]   Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure [J].
Baggio, LL ;
Huang, QL ;
Brown, TJ ;
Drucker, DJ .
GASTROENTEROLOGY, 2004, 127 (02) :546-558
[7]   GUT HORMONE-RELEASE AFTER INTESTINAL RESECTION [J].
BESTERMAN, HS ;
ADRIAN, TE ;
MALLINSON, CN ;
CHRISTOFIDES, ND ;
SARSON, DL ;
PERA, A ;
LOMBARDO, L ;
MODIGLIANI, R ;
BLOOM, SR .
GUT, 1982, 23 (10) :854-861
[8]   GUT HORMONES IN INFLAMMATORY BOWEL-DISEASE [J].
BESTERMAN, HS ;
MALLINSON, CN ;
MODIGLIANI, R ;
CHRISTOFIDES, ND ;
PERA, A ;
PONTI, V ;
SARSON, DL ;
BLOOM, SR .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1983, 18 (07) :845-852
[9]   Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis [J].
Boushey, RP ;
Yusta, B ;
Drucker, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (05) :E937-E947
[10]   Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene [J].
Boushey, RP ;
Abadir, A ;
Flamez, D ;
Baggio, LL ;
Li, YZ ;
Berger, V ;
Marshall, BA ;
Finegood, D ;
Wang, TC ;
Schuit, F ;
Drucker, DJ .
GASTROENTEROLOGY, 2003, 125 (04) :1164-1174